Victory Capital Management Inc. Trims Position in Humana Inc. (NYSE:HUM)

Victory Capital Management Inc. trimmed its stake in Humana Inc. (NYSE:HUM) by 2.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,586 shares of the insurance provider’s stock after selling 2,876 shares during the period. Victory Capital Management Inc. owned about 0.09% of Humana worth $33,760,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. Pzena Investment Management LLC boosted its holdings in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the period. Davis Selected Advisers lifted its holdings in shares of Humana by 16.1% in the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after buying an additional 321,233 shares during the period. Marshall Wace LLP lifted its holdings in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the period. Legal & General Group Plc grew its position in shares of Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after buying an additional 24,842 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Humana by 2.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,018,248 shares of the insurance provider’s stock valued at $380,368,000 after acquiring an additional 20,891 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on HUM shares. Piper Sandler downgraded shares of Humana from an “overweight” rating to a “neutral” rating and cut their target price for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. Truist Financial reduced their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, TD Cowen upped their price objective on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $315.86.

Humana Stock Down 2.6 %

Shares of HUM stock opened at $275.67 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The firm has a market capitalization of $33.19 billion, a PE ratio of 24.42, a P/E/G ratio of 2.29 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s 50-day simple moving average is $281.36 and its 200-day simple moving average is $331.61.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Equities analysts expect that Humana Inc. will post 15.83 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.